Fortrea Holdings (FTRE) Operating Leases (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Operating Leases came in at $54.3 million in Q2 2026, up 2.65% on a YoY basis from $52.9 million in Q2 2025, and down 2.51% quarter-over-quarter from $55.7 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Operating Leases (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Operating Leases for 5 consecutive years, with $54.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Leases rose 2.65% year-over-year to $54.3 million; the trailing twelve-month figure through Jun 2026 stood at $54.3 million (up 2.65% YoY), and the FY2025 full-year result was $54.0 million, down 27.03% from the prior year.
- Operating Leases declined to $54.3 million in Q2 2026 per FTRE's latest filing, from $55.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $80.0 million in Q4 2023 and bottomed at $51.5 million in Q3 2025.
- Historically, Operating Leases has averaged $61.2 million across 5 years, with a median of $59.3 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Operating Leases grew 26.18% in 2023, then decreased 27.03% in 2025.
- Over 5 years, Operating Leases stood at $63.4 million in 2022, then rose by 26.18% to $80.0 million in 2023, then retreated by 7.5% to $74.0 million in 2024, then fell by 27.03% to $54.0 million in 2025, then rose by 0.56% to $54.3 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $54.3 million, $55.7 million, and $54.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.30 Mn |
| Mar 31, 2026 | 55.70 Mn |
| Dec 31, 2025 | 54.00 Mn |
| Sep 30, 2025 | 51.50 Mn |
| Jun 30, 2025 | 52.90 Mn |
| Mar 31, 2025 | 59.10 Mn |
| Dec 31, 2024 | 74.00 Mn |
| Sep 30, 2024 | 65.40 Mn |
| Jun 30, 2024 | 65.80 Mn |
| Mar 31, 2024 | 59.50 Mn |
| Dec 31, 2023 | 80.00 Mn |
| Sep 30, 2023 | 68.00 Mn |
| Jun 30, 2023 | 52.90 Mn |
| Dec 31, 2022 | 63.40 Mn |